Cargando…
Lin28b is involved in curcumin-reversed paclitaxel chemoresistance and associated with poor prognosis in hepatocellular carcinoma
Chemoresistance remains a big challenge in hepatocellular carcinoma (HCC) treatment. Several studies indicated that RNA-binding protein Lin28B serves an oncogenic role in HCC, but its activity in HCC chemotherapy has never been assessed. In this study, we found that overexpression of Lin28B signific...
Autores principales: | Tian, Nan, Shangguan, Wenbing, Zhou, Zuolin, yao, Yao, Fan, Chunlei, Cai, Lijun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6856568/ https://www.ncbi.nlm.nih.gov/pubmed/31762817 http://dx.doi.org/10.7150/jca.33421 |
Ejemplares similares
-
Lin28A/CENPE Promoting the Proliferation and Chemoresistance of Acute Myeloid Leukemia
por: Shi, Mingyue, et al.
Publicado: (2021) -
High LIN28A and PLK4 co-expression is associated with poor prognosis in epithelial ovarian cancer
por: He, Yao, et al.
Publicado: (2018) -
High expression of Lin28 is associated with tumour aggressiveness and poor prognosis of patients in oesophagus cancer
por: Hamano, R, et al.
Publicado: (2012) -
ATRT-12. LIN28A expression correlates with poor prognosis and the MYC subgroup in AT/RTs
por: Dottermusch, Matthias, et al.
Publicado: (2022) -
Increased Expression of Lin28B Associates with Poor Prognosis in Patients with Oral Squamous Cell Carcinoma
por: Wu, Tianfu, et al.
Publicado: (2013)